{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:16:58Z","timestamp":1787847418729,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>The donor vigilance program is intended to collect and assess information on unexpected or undesirable effects or reactions resulting from blood donation. In this report, we discuss the analysis of the blood donor adverse reactions (DARs) reported in the National Blood Donor Vigilance Programme of India during the first 2 years of implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>DAR reporting form prepared and approved by the National Executive Committee of the Haemovigilance Programme of India was used to capture the data by the blood centers and submitted to Donor-Vigil software prepared and hosted by the official website of the National Institute of Biologicals. Data reported for the years 2016 and 2017 were reviewed, analyzed, and validated by independent transfusion medicine experts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>During this period, a total of 19,98,101 donations denominator data were reported, in which 1,622,600 (80.9%) were valid. A total of 6091 DARs were reported, out of which 3980 (65.35%) were found valid. Only validated numerator and denominator data were included in the analysis. Generalized DARs were the most common type of DARs reported (83.7%), followed by \u201cothers\u201d type (7.7%), localized (7.6%), allergic (0.4%), and complications related to apheresis (0.4%). The overall DAR rate was 2.45\/1000 blood donations, which was higher in apheresis donations (3.07\/1000) as compared to whole blood donations (2.39\/1000). The DARs rates were higher in females (3.5\/1000) compared to male donors (2.3\/1000) and in the first time (2.5\/1000) compared to repeat donors (2.15\/1000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In this report, we concluded that younger age, first time, and female donors are more prone to DARs as compared to older age, repeat, and male donors. During the analysis of the data, we found some limitations, which can be improved by upgrading the reporting form and conducting regular continuing medical education (CMEs) of participant blood centers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_195_20","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T08:22:32Z","timestamp":1623486152000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["National blood donor vigilance programme of India"],"prefix":"10.4103","volume":"15","author":[{"given":"Akanksha","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyam","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal K.","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reba","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1423-0410.2010.01442.x","article-title":"Haemovigilance: An effective tool for improving transfusion practice","volume":"100","author":"de Vries","year":"2011","journal-title":"Vox Sang"},{"key":"R2-1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ajts.AJTS_5_18","article-title":"Haemovigilance Programme of India: Analysis of transfusion reactions reported from January 2013 to April 2016 and key recommendations for blood safety","volume":"12","author":"Bisht","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"R3-1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-6247.175384","article-title":"National blood donor vigilance programme: India","volume":"10","author":"Bisht","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"R5-1-20240830","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/vox.12323","article-title":"Development of standard definitions for surveillance of complications related to blood donation","volume":"110","author":"Goldman","year":"2016","journal-title":"Vox Sang"},{"key":"R13-1-20240830","first-page":"46","article-title":"Adverse reactions in whole blood donors: An Indian scenario","volume":"9","author":"Pathak","year":"2011","journal-title":"Blood Transfus"},{"key":"R14-1-20240830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/1658-5127.171989","article-title":"Prevalence of acute adverse reactions among whole blood donors: A 7-year study","volume":"6","author":"Kumari","year":"2015","journal-title":"J Appl Hematol"},{"key":"R15-1-20240830","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0973-6247.98922","article-title":"Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India","volume":"6","author":"Agnihotri","year":"2012","journal-title":"Asian J Transf Sci"},{"key":"R16-1-20240830","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/voxs.12548","article-title":"Incidence and analysis of blood donor adverse reactions-an opportunity to establish a donor vigilance program at an institution in eastern India","volume":"15","author":"Biswas","year":"2020","journal-title":"ISBT Sci Ser"},{"key":"R17-1-20240830","first-page":"1575","article-title":"A retrospective study of adverse events in blood donors from Navi Mumbai","volume":"2","author":"Gupta","year":"2013","journal-title":"J Evol Med Dent"},{"key":"R18-1-20240830","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12288-014-0396-y","article-title":"Study of adverse whole blood donor reactions in normal healthy blood donors: Experience of tertiary health care centre in Jammu region","volume":"31","author":"Dogra","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R19-1-20240830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0973-6247.165840","article-title":"Complications related to blood donation: A multicenter study of the prevalence and influencing factors in voluntary blood donation camps in Karnataka, India","volume":"10","author":"Agarwal","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"R20-1-20240830","first-page":"31","article-title":"Adverse reaction in whole blood donors at a tertiary care centre, Gwalior","volume":"17","author":"Rai","year":"2018","journal-title":"IOSR Journal of Dental and Medical Sciences (IOSR-JDMS"},{"key":"R21-1-20240830","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0973-6247.67020","article-title":"Allergic contact dermatitis to antiseptic medicated dressing applied on phlebotomy site","volume":"4","author":"Dhawan","year":"2010","journal-title":"Asian J Transfus Sci"},{"key":"R22-1-20240830","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12288-015-0568-4","article-title":"Active hemovigilance significantly improves reporting of acute non-infectious adverse reactions to blood transfusion","volume":"32","author":"Agnihotri","year":"2016","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_195_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:17:13Z","timestamp":1787843833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_195_20"}},"subtitle":["Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017)"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_195_20","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}